Participated · Seed · Oct 2024

Infactory is a generative AI–based fact-checking startup founded and led by Brooke Hartley Moy (CEO) and Ken Kocienda (CTO), both ex-Humane.AI. The company broke cover in July via a TechCrunch article and emphasizes using generative AI selectively to address online fact-checking. Infactory says it will not use large language models to generate fact-check results; instead LLMs will be used to determine the intent of natural-language search queries. The team prioritizes vetting data vendors over content providers and aims to be selective in partnerships to ensure accuracy. The startup raised a $4M seed at a $25M valuation and plans to use the funding to expand the team and ramp up go-to-market efforts. Kocienda’s 26-year Apple iPhone engineering background is noted as part of the founding team’s credentials. Infactory is building a fact-checking search engine that uses large language models for a natural-language interface while deliberately avoiding generative AI in the results themselves. The service will pull and collate data directly from trusted data vendors and include citations to reduce hallucinations common to generative models. At launch the product will focus exclusively on computational, data-driven queries rather than subjective topics, targeting enterprise subscribers such as newsrooms and research facilities. The company plans subscription pricing aimed at enterprise customers. Infactory is led by CEO Brooke Hartley Moy and CTO Ken Kocienda, both ex-Humane employees, and says a public launch is coming in a matter of months. The founders have raised a pre-seed round (amount and investors not disclosed) and plan to focus on a seed round in the next six to 18 months.

Participated · Seed · Mar 2024

Yolk.fm is a social media platform centered on non-text, short-form visual interactions using emojis and dynamic stickers. Users can create dynamic stickers from selfies, hand gestures, or surrounding objects and use them to interact with other users' dynamic content and static photos. The service emphasizes fast, image-first communication rather than written text. Yolk.fm is operated by parent company Drigmo. The company recently completed a financing event, indicating early-stage investor interest. No operating metrics or product roadmap details were provided in the article.

Participated · Seed · Sep 2022

Remedial Health provides a platform that lets pharmacies and hospitals order pharmaceutical products from verified manufacturers and distributors while managing inventory, accounting and financial reporting. The company offers inventory financing that allows customers to restock without upfront payment and has an app for inventory management and real-time market intelligence for manufacturers. It serves over 5,000 pharmacies and hospitals, sources more than 8,000 products from about 300 manufacturers (including GSK, Pfizer and AstraZeneca), and reports client count growth of 3x since November and 7x growth in clients and revenues over the past 10 months. Remedial operates a network of regional distribution hubs and performs last-mile delivery either in-house or via partners. The startup says it has a considerable market share in roughly half of the 34 states where it operates and is prioritizing deeper penetration in rural areas. The company is positioning embedded fintech (payments, lending) alongside its core logistics and procurement services to increase efficiency across Nigeria's pharmaceutical value chain. Remedial Health is a Nigerian health-tech startup that provides a digital procurement platform connecting neighborhood pharmacies and hospitals with certified manufacturers and distributors. Its platform enables ordering and tracking, financial reporting, real-time market intelligence, and a patient medication records (PMR) system, while offering inventory financing and loans to increase basket sizes. The company sources products from major manufacturers and distributors including GSK, Pfizer, AstraZeneca, Orange Drugs, Emzor and Fidson Healthcare, aiming to reduce fake and substandard products. Since February, Remedial has expanded from six to 16 Nigerian states and plans to roll out across the remaining 20 states, while pursuing growth opportunities in East and West Africa. Operational metrics include more than 6x growth in customer numbers since January, over 60% of customers using its inventory finance product, and more than 50% growth in average basket size for those users; orders typically arrive within 24 hours. Founded in 2021 and backed by Y Combinator, the company operates last-mile delivery via in-house distribution hubs and partners. Remedial Health provides a patient medication records (PMR) system and procurement platform that digitizes pharmacy operations, inventory and ordering, and stores patients’ medical records while supporting reporting and accounting. The platform enables pharmacies to place and track orders—which Remedial says it fulfills within 24 hours—conduct inventory monitoring to reduce stockouts, and access an online shop or WhatsApp ordering for less-digitized outlets. The company operates a main distribution center with regional hubs and uses in-house logistics or partners, with plans to integrate with a major Nigerian logistics player for end-to-end delivery. Remedial extends credit/BNPL to pharmacies (sometimes taking 20% deposits or offering full financing) and plans to expand the financing service’s coverage. It currently serves more than 300 pharmacies across six states, sources products from 100+ manufacturers including GSK, Pfizer and AstraZeneca, and aims to expand across Nigeria and into additional African markets by year-end. Founders Samuel Okwuada and Victor Benjamin launched the business in 2020 and participated in Y Combinator’s Winter 2022 cohort.

Participated · Seed · Dec 2020

Hannah Life Technologies develops direct-to-consumer, home-based fertility products aimed at helping couples conceive earlier. Its product line includes the patented twoplus Sperm Guide (medical-grade silicone sperm concentrator), the twoplus Applicator for depositing sperm at the cervical opening, and the twoplus Hormone Test that delivers detailed hormone reports. The products are designed as non-invasive complements to clinic-based procedures such as intra-uterine insemination (IUI). Co-founder Benjamin Tee said he and co-founder Prusothman Raja met through the Stanford Biodesign program and built the company after personal experience with unexplained infertility and IVF. Since launching in August 2021, Hannah Life has supplied products to over a thousand households in Singapore and the United Kingdom and reported revenue growth of over 300% quarter-over-quarter. The company previously raised seed funding from Y Combinator and continues to sell direct-to-consumer. Hannah Life developed a flexible silicone vaginal device that uses proprietary surface features and microenvironment optimization to concentrate sperm at the cervical opening and boost chances of conception without clinic visits or drugs. The founders, Prusothman Sinaraja and Dr. Benjamin Tee, met as Stanford Biodesign Fellows and built the product after personal experience with infertility and invasive treatments. The device is drug-free, intended for monthly at-home use, and the company says it aims to offer pricing at roughly one-tenth the cost of an IUI cycle. The product is currently in closed beta with early positive feedback and an anecdotal report of immediate pregnancy from a Y Combinator partner. Hannah Life plans a Q1 2021 launch of its first product and expects to release 2–3 additional products during the year while pursuing distribution through clinics, retail, pharmacies, and potential employer benefits. The team positions the suite as complementary to existing fertility treatments and as a more affordable, private option for couples seeking to increase conception odds.